Grandiflorenic acid isolated from Sphagneticola trilobata against Trypanosoma cruzi: Toxicity, mechanisms of action and immunomodulation.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 11 08 2021
revised: 15 10 2021
accepted: 18 10 2021
pubmed: 25 10 2021
medline: 10 2 2022
entrez: 24 10 2021
Statut: ppublish

Résumé

Grandiflorenic acid (GFA) is one of the main kaurane diterpenes found in different parts of Sphagneticola trilobata. It has several biological activities, especially antiprotozoal action. In turn, Chagas disease is a complex systemic disease caused by the protozoan Trypanosoma cruzi, and the drugs available to treat it involve significant side effects and impose an urgent need to search for therapeutic alternatives. In this context, our goal was to determine the effect of GFA on trypomastigote and intracellular amastigote forms. Our results showed that GFA treatment led to significantly less viability of trypomastigote forms, with morphological and ultrastructural changes in the parasites treated with IC

Identifiants

pubmed: 34688839
pii: S0887-2333(21)00192-2
doi: 10.1016/j.tiv.2021.105267
pii:
doi:

Substances chimiques

Antiprotozoal Agents 0
Diterpenes 0
Reactive Oxygen Species 0
Tumor Necrosis Factor-alpha 0
grandiflorenic acid 22338-67-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105267

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Manoela Daiele Gonçalves (MD)

Department of Chemical, Center of Exact Sciences, State University of Londrina, PR, Brazil. Electronic address: mahgonn@hotmail.com.

Bruna Taciane da Silva Bortoleti (BTDS)

Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, PR, Brazil; Biosciences and Biotechnology Postgraduate Program, Carlos Chagas Institute, ICC/Fiocruz/PR, Curitiba, PR, Brazil.

Fernanda Tomiotto-Pellissier (F)

Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, PR, Brazil; Biosciences and Biotechnology Postgraduate Program, Carlos Chagas Institute, ICC/Fiocruz/PR, Curitiba, PR, Brazil.

Virginia Marcia Concato (VM)

Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, PR, Brazil.

Ricardo Luís Nascimento de Matos (RLN)

Department of Chemical, Center of Exact Sciences, State University of Londrina, PR, Brazil.

Taylon Felipe Silva (TF)

Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, PR, Brazil.

Ana Carolina Jacob Rodrigues (ACJ)

Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, PR, Brazil; Biosciences and Biotechnology Postgraduate Program, Carlos Chagas Institute, ICC/Fiocruz/PR, Curitiba, PR, Brazil.

Amanda Cristina Machado Carloto (ACM)

Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, PR, Brazil.

Idessania Nazareth Costa (IN)

Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, PR, Brazil.

Danielle Lazarin-Bidóia (D)

Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, PR, Brazil.

Milena Menegazzo Miranda-Sapla (MM)

Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, PR, Brazil.

Wander Rogério Pavanelli (WR)

Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, PR, Brazil.

Nilton Syogo Arakawa (NS)

Department of Chemical, Center of Exact Sciences, State University of Londrina, PR, Brazil.

Ivete Conchon-Costa (I)

Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, PR, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH